Medicare Enrolled
Ignacio Cendan
Pulmonary Disease · Miami, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Cendan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Cendan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Cendan
Ignacio Cendan is a pulmonary disease specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Cendan performed 2,196 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Cendan received a total of $140,407 from 44 pharmaceutical and/or device companies across 755 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Cendan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 29% volume in FL
$140,407 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 50221 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗2,196
Medicare services
Top 29% in FL for pulmonary disease
Not available
Unique patients (not deduplicated)
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
967 | $68 | $238 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
387 | $102 | $354 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
345 | $103 | $343 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
164 | $112 | $462 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
58 | $31 | $190 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
58 | $45 | $170 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
58 | $45 | $179 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $141 | $545 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
54 | $43 | $131 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
34 | $24 | $105 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $154 | $476 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$140,407
Total received (2018-2024)
Avg $20,058/year across 7 years
Top 3% in FL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
755
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$12,191
2023
$30,333
2022
$33,505
2021
$28,187
2020
$12,262
2019
$20,904
2018
$3,026
Payments by company (2024)
GlaxoSmithKline, LLC.
$10,172
AstraZeneca Pharmaceuticals LP
$348
Boehringer Ingelheim Pharmaceuticals, Inc.
$280
Mallinckrodt Hospital Products Inc.
$202
Insmed, Inc.
$178
Ethicon Inc.
$168
Inspire Medical Systems, Inc.
$158
E.R. Squibb & Sons, L.L.C.
$125
SANOFI-AVENTIS U.S. LLC
$95
GENZYME CORPORATION
$95
Regeneron Healthcare Solutions, Inc.
$73
Takeda Pharmaceuticals U.S.A., Inc.
$64
Actelion Pharmaceuticals US, Inc.
$63
Baxter Healthcare
$44
United Therapeutics Corporation
$29
Paratek Pharmaceuticals, Inc.
$23
Mylan Specialty L.P.
$22
Bayer Healthcare Pharmaceuticals Inc.
$19
Amgen Inc.
$16
Hikma Pharmaceuticals USA
$16
Top 3 companies account for 88.6% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$124,717
AstraZeneca Pharmaceuticals LP
$2,878
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,585
Actelion Pharmaceuticals US, Inc.
$1,858
ViiV Healthcare Company
$1,600
Mallinckrodt Hospital Products Inc.
$671
Insmed, Inc.
$635
Mylan Specialty L.P.
$483
Ethicon Inc.
$413
Sunovion Pharmaceuticals Inc.
$397
GENZYME CORPORATION
$362
Genentech USA, Inc.
$356
Philips Electronics North America Corporation
$279
Takeda Pharmaceuticals U.S.A., Inc.
$249
E.R. Squibb & Sons, L.L.C.
$246
Allergan Inc.
$233
AbbVie Inc.
$220
ABBVIE INC.
$216
Bayer HealthCare Pharmaceuticals Inc.
$214
Regeneron Healthcare Solutions, Inc.
$178
PORTOLA PHARMACEUTICALS, INC.
$166
Inspire Medical Systems, Inc.
$158
Paratek Pharmaceuticals, Inc.
$142
United Therapeutics Corporation
$129
TETRAPHASE PHARMACEUTICALS, INC.
$121
Baxter Healthcare
$106
Inogen, Inc.
$97
SANOFI-AVENTIS U.S. LLC
$95
Bayer Healthcare Pharmaceuticals Inc.
$75
Amgen Inc.
$72
Advanced Respiratory, Inc
$69
Medtronic, Inc.
$59
Shire North American Group Inc
$56
Electromed, Inc.
$52
Teva Pharmaceuticals USA, Inc.
$41
Mallinckrodt LLC
$31
PFIZER INC.
$30
Allergan, Inc.
$24
Jazz Pharmaceuticals Inc.
$19
La Jolla Pharmaceutical Company
$17
Optinose US, Inc.
$17
Hikma Pharmaceuticals USA
$16
Lilly USA, LLC
$13
CMP Pharma, Inc.
$13
Top 3 companies account for 92.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · Arikayce · ArmonAir Digihaler · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CINQAIR · CUVITRU · DALVANCE · DUPIXENT · Dymista · Esbriet · FASENRA · GIAPREZA · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hillrom - Volara System · ILLUMISITE · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · LONHALA MAGNAIR · Life 2000 Ventilation System · MOUNJARO · Monarch Platform · NUCALA · NUZYRA · OFEV · OPDIVO · OPSUMIT · OPSUMIT MACITENTAN · Ryaltris · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · Tadliq · UPTRAVI · UTIBRON · UTIBRON NEOHALER · Utibron · Wellcentive Undiv · Xerava · Xhance · Xolair · Xyrem · YUPELRI · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
104
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
SOUTH MIAMI HOSPITAL
2.4 mi
2.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Cendan is a clinical cardiology specialist, with above-average Medicare volume (top 29% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Cendan experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Cendan performed 967 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Cendan receive payments from pharmaceutical companies?
Yes. Cendan received a total of $140,407 from 44 companies across 755 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Cendan's costs compare to other pulmonary diseases in Miami?
Cendan's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Cendan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Miami
Browse pulmonary diseases in Miami ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology